InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Robichaud Albert, Directeur Scientifique. Officer active across 1 company, notably Sage Therapeutics, Inc.. Cumulatively, 6 reports have been published. Split: 0 buy · 1 sell. Activity tracked since 15 June 2021. The latest transaction was filed on 3 February 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
3,375 shares0Common StockSEC:0001562180-23-001082:0
3,800 shares0Common StockSEC:0001562180-21-006599:0
3,800 shares0Common StockSEC:0001562180-21-006599
4,000 shares0Common StockSEC:0001562180-21-004339
4,000 shares0Common StockSEC:0001562180-21-004339:0
20,000 sharesCommon StockSEC:0001562180-16-001395:0
6 of 6 declarations
About Robichaud Albert
Albert Robichaud is the Chief Scientific Officer at Sage Therapeutics, Inc. He is responsible for leading research and development initiatives, playing a key role in the innovation and advancement of the company's products.
